Gary A. Gelbfish, Director at CorMedix Inc. (CRMD), bought 23,300 shares at $0.33 ($8K) on 2011-12-16, disclosed to the SEC on 2011-12-20.
Open-market purchase of $8k CRMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.